Loading…
Loading…
In person · Pittsburgh · PA · United States
Research provider: Pitt+Me
Do you have cystic fibrosis? You may be eligible to help advance new treatments for cystic fibrosis and chronic Achromobacter infections. This research study is to evaluate the safety and tolerability of AchromoPhage in adults with cystic fibrosis and chronic Achromobacter infection. Compensation is provided.
This study requires 7 study visits. Study visits 1, 2, and 3 will last about 4 hours. Study visits 4, 5, 6, and 7 will last approximately 1 hour. Study visits 1, 2, and 3, you will be randomly assigned to receive IV, inhaled, or IV and inhaled AchromoPhage. Additionally, this study will be asking people to complete a series of questionnaires about their quality of life, a study diary, and spirometry testing, and will collect blood, urine, nasal swabs, and throat swabs.
Do you have cystic fibrosis? You may be eligible to help advance new treatments for cystic fibrosis and chronic Achromobacter infections. This research study is to evaluate the safety and tolerability of AchromoPhage in adults with cystic fibrosis and chronic Achromobacter infection. Compensation is provided.
Review the provider’s screening questions. These requirements do not guarantee selection.